Related Experiment Videos
Blood coagulation in healthy and severely ill newborn infants
Insights
This study establishes normal blood coagulation factor ranges in newborns. Six of eight infants with disseminated intravascular coagulation (DIC) improved with treatment of underlying conditions and procoagulant replacement, avoiding heparin.
Area of Science:
- Neonatal Medicine
- Hematology
- Pediatric Coagulation
Background:
- Disseminated intravascular coagulation (DIC) is a complex hematological disorder.
- Neonatal DIC often presents with serious underlying conditions.
- Establishing normal coagulation factor ranges in healthy newborns is crucial for diagnosis.
Purpose of the Study:
- To determine normal values for blood coagulation factors in healthy newborn infants.
- To evaluate infants with DIC using established normal standards.
- To discuss diagnostic criteria and management strategies for neonatal DIC.
Main Methods:
- Investigated normal values of blood coagulation factors in 30 healthy newborn infants.
- Evaluated 8 infants diagnosed with DIC based on these normal standards.
- Assessed treatment efficacy through clinical outcomes and resolution of bleeding disorders.
Main Results:
- Established reference ranges for neonatal blood coagulation factors.
- Six out of eight infants with DIC showed resolution of bleeding after treatment.
- Treatment involved addressing the primary disorder and replacing depleted procoagulants.
Conclusions:
- Neonatal DIC is associated with severe underlying diseases.
- Effective management can be achieved through treating the primary condition and procoagulant replacement.
- Heparinization may not be necessary in all cases of neonatal DIC.
Abstract:
Normal values of blood coagulation factors were investigated in 30 healthy newborn infants. On the basis of these normal standards 8 infants with DIC were evaluated. All of them had serious underlying diseases. By appropriate treatment of the primary disorder and replacement of depleted procoagulants, the bleeding disorder disappeared in six of eight patients without heparinization. Diagnostic criteria and management of neonatal disseminated intravascular coagulation are discussed.